ArticleJournal for immunotherapy of cancer2020

Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab.

Yutaka Natori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.